Insider Selling: Cabot Co. (NYSE:CBT) EVP Sells 14,566 Shares of Stock

Cabot Co. (NYSE:CBT) EVP Jeff Ji Zhu sold 14,566 shares of the stock in a transaction on Wednesday, November 13th. The shares were sold at an average price of $113.25, for a total transaction of $1,649,599.50. Following the completion of the sale, the executive vice president now directly owns 69,449 shares of the company’s stock, valued at approximately $7,865,099.25. This trade represents a 17.34 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Jeff Ji Zhu also recently made the following trade(s):

• On Monday, August 26th, Jeff Ji Zhu sold 1,201 shares of Cabot stock. The stock was sold at an average price of $106.19, for a total value of $127,534.19.

Cabot Trading Down 0.3 %

Shares of Cabot stock opened at $108.81 on Friday. Cabot Co. has a 1 year low of $70.63 and a 1 year high of $117.46. The firm’s 50 day moving average is $110.16 and its 200 day moving average is $102.13. The company has a current ratio of 2.08, a quick ratio of 1.36 and a debt-to-equity ratio of 0.68. The firm has a market capitalization of $5.96 billion, a PE ratio of 16.14, a price-to-earnings-growth ratio of 0.94 and a beta of 1.20.

Cabot (NYSE:CBT) last released its quarterly earnings data on Monday, November 4th. The specialty chemicals company reported $1.80 earnings per share for the quarter, missing the consensus estimate of $1.81 by ($0.01). Cabot had a net margin of 9.51% and a return on equity of 26.60%. The company had revenue of $1 billion during the quarter, compared to the consensus estimate of $1.01 billion. During the same quarter in the prior year, the firm earned $1.65 EPS. The business’s revenue was up 3.7% compared to the same quarter last year. Equities research analysts forecast that Cabot Co. will post 7.7 earnings per share for the current fiscal year.

Cabot Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 13th. Stockholders of record on Friday, November 29th will be paid a $0.43 dividend. The ex-dividend date of this dividend is Friday, November 29th. This represents a $1.72 annualized dividend and a dividend yield of 1.58%. Cabot’s payout ratio is 25.52%.

Analyst Upgrades and Downgrades

CBT has been the topic of several recent research reports. UBS Group decreased their price target on Cabot from $103.00 to $98.00 and set a “neutral” rating on the stock in a report on Tuesday, August 6th. JPMorgan Chase & Co. downgraded Cabot from a “neutral” rating to an “underweight” rating and set a $105.00 price objective on the stock. in a research note on Monday, November 11th. Finally, Mizuho upped their target price on shares of Cabot from $103.00 to $122.00 and gave the stock an “outperform” rating in a research note on Tuesday, November 5th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $105.00.

Institutional Trading of Cabot

Several institutional investors and hedge funds have recently bought and sold shares of the company. Wolff Wiese Magana LLC purchased a new stake in shares of Cabot in the 3rd quarter valued at $25,000. CWM LLC lifted its position in Cabot by 60.6% during the second quarter. CWM LLC now owns 416 shares of the specialty chemicals company’s stock valued at $38,000 after buying an additional 157 shares during the period. UMB Bank n.a. grew its stake in shares of Cabot by 53.9% in the 3rd quarter. UMB Bank n.a. now owns 371 shares of the specialty chemicals company’s stock worth $41,000 after buying an additional 130 shares during the last quarter. Farther Finance Advisors LLC raised its holdings in Cabot by 197.9% in the third quarter. Farther Finance Advisors LLC now owns 417 shares of the specialty chemicals company’s stock worth $47,000 after buying an additional 277 shares during the last quarter. Finally, EverSource Wealth Advisors LLC raised its stake in shares of Cabot by 33.4% in the second quarter. EverSource Wealth Advisors LLC now owns 475 shares of the specialty chemicals company’s stock worth $48,000 after purchasing an additional 119 shares during the last quarter. 93.18% of the stock is currently owned by hedge funds and other institutional investors.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.